Literature DB >> 18182322

Clipping, shedding and RIPping keep immunity on cue.

Gillian Murphy1, Aditya Murthy, Rama Khokha.   

Abstract

Exposure to infectious agents elicits defense mechanisms that necessitate a timely immune response. The immediate delivery of essential cues for immune activation is provided, in part, by proteolytic processing. A large repertoire of molecules orchestrates the activation, migration, and effector function of immune cells. The diversity of this repertoire matches well with the broad array of substrates that can be cleaved by proteinases, and many of these substrates are proving to be essential for proper immune-cell function. Here, we discuss how two specific classes of metal-dependent proteinases, the matrix metalloproteinases and the disintegrin metalloproteinases, have consequences well beyond classical cell-matrix and cell-cell interactions and motility, and we review their roles in immune-cell maturation, clonal expansion, and cytotoxic functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182322     DOI: 10.1016/j.it.2007.10.009

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  38 in total

1.  Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.

Authors:  Gillian Murphy
Journal:  Int J Exp Pathol       Date:  2010-08       Impact factor: 1.925

2.  Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17.

Authors:  Juan Guinea-Viniegra; Rainer Zenz; Harald Scheuch; María Jiménez; Latifa Bakiri; Peter Petzelbauer; Erwin F Wagner
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

3.  Soluble RANKL Cleaved from Activated Lymphocytes by TNF-α-Converting Enzyme Contributes to Osteoclastogenesis in Periodontitis.

Authors:  Hiroyuki Kanzaki; Seicho Makihira; Maiko Suzuki; Takenobu Ishii; Alexandru Movila; Josefine Hirschfeld; Hani Mawardi; Xiaoping Lin; Xiaozhe Han; Martin A Taubman; Toshihisa Kawai
Journal:  J Immunol       Date:  2016-10-07       Impact factor: 5.422

4.  Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.

Authors:  Will S Driscoll; Tomas Vaisar; Jingjing Tang; Carole L Wilson; Elaine W Raines
Journal:  Circ Res       Date:  2013-04-12       Impact factor: 17.367

5.  Conditional inactivation of TACE by a Sox9 promoter leads to osteoporosis and increased granulopoiesis via dysregulation of IL-17 and G-CSF.

Authors:  Keisuke Horiuchi; Tokuhiro Kimura; Takeshi Miyamoto; Kana Miyamoto; Haruhiko Akiyama; Hironari Takaishi; Hideo Morioka; Takashi Nakamura; Yasunori Okada; Carl P Blobel; Yoshiaki Toyama
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

6.  Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.

Authors:  Vincent E de Meijer; Deanna Y Sverdlov; Yury Popov; Hau D Le; Jonathan A Meisel; Vânia Nosé; Detlef Schuppan; Mark Puder
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

7.  ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progression.

Authors:  David M Gravano; Bryce T McLelland; Keisuke Horiuchi; Jennifer O Manilay
Journal:  PLoS One       Date:  2010-10-20       Impact factor: 3.240

8.  TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.

Authors:  Juan Guinea-Viniegra; Rainer Zenz; Harald Scheuch; Denes Hnisz; Martin Holcmann; Latifa Bakiri; Helia B Schonthaler; Maria Sibilia; Erwin F Wagner
Journal:  Genes Dev       Date:  2009-11-15       Impact factor: 11.361

9.  Simultaneous transforming growth factor beta-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart.

Authors:  Zamaneh Kassiri; Virginie Defamie; Mehrdad Hariri; Gavin Y Oudit; Shalini Anthwal; Fayez Dawood; Peter Liu; Rama Khokha
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

10.  TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.

Authors:  Marina Cardellini; Rossella Menghini; Eugenio Martelli; Viviana Casagrande; Arianna Marino; Stefano Rizza; Ottavia Porzio; Alessandro Mauriello; Anna Solini; Arnaldo Ippoliti; Renato Lauro; Franco Folli; Massimo Federici
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.